Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo

被引:165
|
作者
Bekkering, Siroon [1 ,4 ]
van den Munckhof, Inge [1 ]
Nielen, Tim [2 ]
Lamfers, Evert [2 ]
Dinarello, Charles [1 ,3 ]
Rutten, Joost [1 ]
de Graaf, Jacqueline [1 ]
Joosten, Leo A. B. [1 ]
Netea, Mihai G. [1 ]
Gomes, Marc E. R. [2 ]
Riksen, Niels P. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, 463,POB 9101, NL-6500 HB Nijmegen, Netherlands
[2] Canisius Wilhelmina Hosp, Dept Cardiol, Nijmegen, Netherlands
[3] Univ Colorado Denver, Aurora, CO 80045 USA
[4] Acad Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands
关键词
Atherosclerosis; Monocytes; Inflammation; Metabolism; Epigenetics; ACUTE CORONARY SYNDROMES; INTIMA-MEDIA THICKNESS; FAMILIAL HYPERCHOLESTEROLEMIA; CYTOKINE PRODUCTION; CAROTID PLAQUES; MONOCYTES; LIPOPROTEIN(A); MACROPHAGES; REINFECTION; PROTECTION;
D O I
10.1016/j.atherosclerosis.2016.10.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: We have recently reported that monocytes can undergo functional and transcriptional reprogramming towards a long-term pro-inflammatory phenotype after brief in vitro exposure to atherogenic stimuli such as oxidized LDL. This process is termed 'trained immunity', and is mediated by epigenetic remodeling and a metabolic switch towards increased aerobic glycolysis. We hypothesize that trained immunity contributes to atherogenesis. Therefore, we investigated the inflammatory phenotype and epigenetic remodeling of monocytes from patients with and without established atherosclerosis. Methods: Monocytes were isolated from 20 patients with severe symptomatic coronary atherosclerosis (total plaque score >4 on coronary computed tomography angiography) and 17 patients with asymptomatic carotid atherosclerosis and matched controls for both groups. Ex vivo stimulation, RNA analysis and chromatin immunoprecipitation were performed. Results: Monocytes from patients with symptomatic atherosclerosis have a higher production of pro-inflammatory cytokines upon LPS stimulation than healthy controls (TNF alpha 499 +/- 102 vs. 267 +/- 45 pg/ml, p = 0.01). This was associated with lower histone 3 lysine 4 trimethylation (H3K4me3) (19% vs. 33%, p = 0.002), and lower H3K27me3 (0.005% vs. 0.8%, p < 0.0001) on the TNF alpha promoter. Furthermore, relative mRNA expression of the glycolytic rate limiting enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 was higher in patients (0.7 +/- 0.2 vs. 0.3 +/- 0.1 resp. 1.7 +/- 0.2 vs. 1.0 +/- 0.1, p = 0.007 resp. 0.003) compared to control individuals. Interestingly, this pro-inflammatory phenotype was only present in patients with symptomatic atherosclerosis, and not in patients with asymptomatic carotid atherosclerosis. Conclusions: Circulating monocytes of patients with symptomatic, but not asymptomatic, atherosclerosis have a pro-inflammatory phenotype and increased expression of glycolytic enzymes, associated with epigenetic remodeling at the level of histone methylation. (C) 2016 The Authors. Published by Elsevier Ireland Ltd.
引用
收藏
页码:228 / 236
页数:9
相关论文
共 50 条
  • [31] No interplay between gut microbiota composition and the lipopolysaccharide-induced innate immune response in humans in vivo
    Habes, Quirine Lm
    Konstanti, Prokopis
    Kiers, Harmke D.
    Koch, Rebecca M.
    Stolk, Roeland F.
    Belzer, Clara
    Kox, Matthijs
    Pickkers, Peter
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (04)
  • [32] Group 2 Innate Lymphoid Cells Directly Induce B Cell Activation in Humans
    Kasjanski, Richard
    Kato, Atsushi
    Poposki, Julie A.
    Bochner, Bruce S.
    Cao, Yun
    Norton, James E.
    Suh, Lydia
    Carter, Roderick G.
    Kern, Robert C.
    Smith, Stephanie S.
    Conley, David B.
    Peters, Anju T.
    Grammer, Leslie C.
    Stevens, Whitney W.
    Harris, Kathleen E.
    Tan, Bruce
    Schleimer, Robert P.
    Hulse, Kathryn E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB1 - AB1
  • [33] NON-INVASIVE IN VIVO IMAGING OF PERIPHERAL MONONUCLEAR CELL MIGRATION TO ATHEROSCLEROSIS IN HUMANS
    van der Valk, F.
    Kroon, J.
    Thurlings, R.
    Verberne, H.
    Nederveen, A.
    van Buul, J.
    Nieuwdorp, M.
    Mulder, W.
    Fayad, Z.
    Stroes, E.
    ATHEROSCLEROSIS, 2014, 235 (02) : E20 - E20
  • [34] Rapid Innate Immune Cell Activation by Partial Hepatectomy Impairs Liver Regeneration
    Alvarez, Navarro N.
    Yang, Y. -G.
    TRANSPLANTATION, 2012, 94 (10) : 447 - 447
  • [35] ALCOHOL IMPAIRS INNATE IMMUNE CELL ACTIVATION: DISTINCT ROLE OF MAP KINASES
    Mandrekar, Pranoti
    Catalano, Donna
    Kodys, Karen
    Szabo, Gyongyi
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (06) : 291A - 291A
  • [36] Non-Invasive in vivo Imaging of Peripheral Mononuclear Cell Migration to Atherosclerosis in Humans
    van der Valk, Fleur
    Potters, Wouter
    de Jong, Matthijs
    Thurlings, Rogier
    Bennink, Roel
    Verberne, Hein
    Dallinga-Thie, Geesje
    Nieuwdorp, Max
    Nederveen, Aart
    Stroes, Erik
    CIRCULATION, 2013, 128 (22)
  • [37] Dual Antibody Conjugation of Fluorescent Nanodiamonds for Targeted Innate Immune Cell Activation
    Johnson, Courtney L.
    Lapurga, Gabriella
    Sun, Steven
    Rampersaud, Isaac
    Fletcher, Charles
    Fletcher, Charles
    Albertson, David
    Savardekar, Himanshu
    Suarez-Kelly, Lorena
    Rampersaud, Arfaan
    Carson, William, III
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S191 - S191
  • [38] Is Cerebrospinal Fluid Responsible for Innate Immune Cell Activation and Neurotoxicity in Multiple Sclerosis?
    Kalaitzidis, Grigorios
    Calabresi, Peter A.
    NEUROLOGY, 2021, 96 (14) : 649 - 650
  • [39] Carbohydrate and Amino Acid Metabolism as Hallmarks for Innate Immune Cell Activation and Function
    Zhao, Haoxin
    Raines, Lydia N.
    Huang, Stanley Ching-Cheng
    CELLS, 2020, 9 (03)
  • [40] Defining PANoptosis: Biochemical and Mechanistic Evaluation of Innate Immune Cell Death Activation
    Tweedell, Rebecca E.
    Hibler, Taylor
    Kanneganti, Thirumala-Devi
    CURRENT PROTOCOLS, 2024, 4 (07):